91
Participants
Start Date
December 3, 2021
Primary Completion Date
November 9, 2023
Study Completion Date
November 9, 2023
Donidalorsen
Donidalorsen was administered by SC injection.
Placebo
Donidalorsen-matching placebo was administered by SC injection.
Ionis Investigative Site, Brussels
Ionis Investigative Site, Brussels
Ionis Investigative Site, Sofia
Ionis Investigative Site, Sofia
Ionis Investigative Site, Edegem
Ionis Investigative Site, Odense
Ionis Investigative Site, Ankara
Ionis Investigative Site, Barcelona
Ionis Investigative Site, Berlin
Ionis Investigative Site, Marseille
Ionis Investigative Site, Hershey
Ionis Investigative Site, Milan
Ionis Investigative Site, Madrid
Ionis Investigative Site, Tampa
Ionis Investigative Site, Istanbul
Ionis Investigative Site, Izmir
Ionis Investigative Site, Padua
Ionis Investigative Site, La Tronche
Ionis Investigative Site, Seville
Ionis Investigative Site, Columbus
Ionis Investigative Site, Toledo
Ionis Investigative Site, Valencia
Ionis Investigative Site, Ann Arbor
Ionis Investigative Site, Frankfurt
Ionis Investigative Site, St Louis
Ionis Investigative Site, Kansas City
Ionis Investigative Site, Paris
Ionis Investigative Site, Dallas
Ionis Investigative Site, Ashkelon
Ionis Investigative Site, Napoli
Ionis Investigative Site, Colorado Springs
Ionis Investigative Site, Munich
Ionis Investigative Site, Murray
Ionis Investigative Site, Scottsdale
Ionis Investigative Site, Palermo
Ionis Investigative Site, Santa Monica
Ionis Investigative Site, San Diego
Ionis Investigative Site, Walnut Creek
Ionis Investigative Site, Catania
Ionis Investigative Site, Haifa
Ionis Investigative Site, Tel Aviv
Ionis Investigative Site, Boston
Ionis Investigative Site, Ottawa
Ionis Investigative Site, Edmonton
Ionis Investigative Site, Amsterdam
Ionis Investigative Site, Groningen
Ionis Investigative Site, Krakow
Ionis Investigative Site, Barcelona
Ionis Investigative Site, Birmingham
Ionis Investigative Site, Bristol
Ionis Investigative Site, London
Lead Sponsor
Ionis Pharmaceuticals, Inc.
INDUSTRY